News
04-13-2020, 01:57 PM
Immunotherapies have revolutionized treatment for people with a variety of cancers. But when given to those with triple-negative breast cancer, a particularly aggressive form of the disease, less than 20% respond.
More... (https://www.news-medical.net/news/20200413/Molecular-pathway-responsible-for-TNBCs-progression-and-spread-identified.aspx)
More... (https://www.news-medical.net/news/20200413/Molecular-pathway-responsible-for-TNBCs-progression-and-spread-identified.aspx)